Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
about
A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signalsSTAT inhibitors for cancer therapy.Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma.Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization.Progress towards the development of SH2 domain inhibitors.Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaSTAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation.Carcinoembryonic Antigen Cell Adhesion Molecule 1 long isoform modulates malignancy of poorly differentiated colon cancer cells.Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsRhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.Targeting STAT3 in gastric cancer.A STAT inhibitor patent review: progress since 2011.Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells.Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors.Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.Identification of Bidentate Salicylic Acid Inhibitors of PTP1B.
P2860
Q28833260-3E7260FE-9B78-49D7-8C48-21E9E1CD2B2FQ33644206-060C9DC3-C547-48D2-8C8A-D0BCAC6E058AQ33820278-88AFF63E-839F-45D6-A55E-151A0804EBF6Q34116434-8119A57D-69F8-4484-91B4-A752961F4AE8Q34552575-7C442F14-3E13-4961-875D-65EC303BA583Q34581878-15961998-D84B-448F-B581-D8C49F9FEECDQ35102414-B0AD8879-0055-4C9C-9B5A-164C9C9720A1Q35757920-AABF43D4-AB65-46F3-8A0E-F0EB232D2CD2Q36782872-630FF91F-D271-4A1C-95DA-ED572A4F4349Q36918125-B0B2671D-CC4A-4160-8B91-7294A2CEE215Q37295115-A434800E-FAE7-4670-9DE3-CAA700B29E39Q38029729-098266A2-0041-4068-84C8-62090FF28C7AQ38591166-D7708B09-3A59-46C9-99FB-29B5D2CDC487Q38905585-1DE871D8-A5D4-44D3-B344-DF65EB827FF0Q39136737-01E11DDE-4AE4-4E7F-9EF3-8EA46CB43427Q39237865-D83A739C-6A32-4D3C-962F-14C662A09894Q39778880-D0E9E665-3BFA-4B00-865A-BD490122EFB8Q43242949-024EBB59-CDD1-416C-B5B2-01991B3E8C99
P2860
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of a non-phosph ...... igand for the Stat3 SH2 domain
@ast
Identification of a non-phosph ...... igand for the Stat3 SH2 domain
@en
type
label
Identification of a non-phosph ...... igand for the Stat3 SH2 domain
@ast
Identification of a non-phosph ...... igand for the Stat3 SH2 domain
@en
prefLabel
Identification of a non-phosph ...... igand for the Stat3 SH2 domain
@ast
Identification of a non-phosph ...... igand for the Stat3 SH2 domain
@en
P2093
P2860
P50
P1476
Identification of a non-phosph ...... igand for the Stat3 SH2 domain
@en
P2093
Brent D G Page
James Turkson
Jeffrey L Wrana
Patrick T Gunning
Peibin Yue
Steven Fletcher
Sumaiya Sharmeen
Xiaolei Zhang
P2860
P304
P356
10.1016/J.BMCL.2011.06.056
P407
P577
2011-06-30T00:00:00Z